Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Citi
Accenture
Boehringer Ingelheim
AstraZeneca
Federal Trade Commission
Express Scripts
Cantor Fitzgerald
Daiichi Sankyo

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040255

« Back to Dashboard

NDA 040255 describes OXYCODONE AND ASPIRIN, which is a drug marketed by Actavis Labs Fl Inc, Mayne Pharma Inc, Sun Pharm Industries, Watson Labs, and Roxane, and is included in six NDAs. It is available from three suppliers. Additional details are available on the OXYCODONE AND ASPIRIN profile page.

The generic ingredient in OXYCODONE AND ASPIRIN is aspirin; oxycodone hydrochloride; oxycodone terephthalate. There are twenty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin; oxycodone hydrochloride; oxycodone terephthalate profile page.
Summary for 040255
Tradename:OXYCODONE AND ASPIRIN
Applicant:Watson Labs
Ingredient:aspirin; oxycodone hydrochloride; oxycodone terephthalate
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 040255
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXYCODONE AND ASPIRIN aspirin; oxycodone hydrochloride; oxycodone terephthalate TABLET;ORAL 040255 ANDA Physicians Total Care, Inc. 54868-2094 E 54868-2094-0
OXYCODONE AND ASPIRIN aspirin; oxycodone hydrochloride; oxycodone terephthalate TABLET;ORAL 040255 ANDA Physicians Total Care, Inc. 54868-2094 E 54868-2094-1

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength325MG;4.5MG;0.38MG
Approval Date:Feb 27, 1998TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Cantor Fitzgerald
AstraZeneca
McKesson
Fuji
Harvard Business School
US Army
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.